NanoPalm is a Saudi bio-deeptech startup founded in 2022 and headquartered in Riyadh. The company specializes in developing nanoparticle-based drug delivery platforms to design innovative nanomedicines that target a wide range of diseases, including rare genetic disorders, aiming to make treatments more accessible, affordable, and easier to administer.